This company has been marked as potentially delisted and may not be actively trading. NYSE:PMC Pharmerica (PMC) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Pharmerica Stock (NYSE:PMC) 30 days 90 days 365 days Advanced Chart Get Pharmerica alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume283,015 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview PharMerica Corporation is an institutional pharmacy services company. The Company services healthcare facilities, provides pharmacy management services to hospitals and specialty infusion services to patients outside a hospital setting, and offers the national oncology pharmacy in the United States. Its segments include institutional pharmacy, which provides pharmacy products and services to residents and patients in skilled nursing facilities, nursing centers, assisted living facilities, hospitals and other long-term alternative care settings; specialty infusion services, which provides specialty infusion services focused on providing pharmaceutical products and clinical services to patients in client facilities, hospice and outside of hospital or nursing home settings, and specialty oncology pharmacy, which provides dispensing of oncology drugs, care management and other related services to patients, oncology practices and hospitals. Read More Receive PMC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Pharmerica and its competitors with MarketBeat's FREE daily newsletter. Email Address PMC Stock News HeadlinesMedicine shortage hits TB elimination programme in PuneMarch 30, 2024 | msn.comFrom next month, PMC hospitals, maternity homes to get generic medicine storesNovember 22, 2023 | msn.comCongress Is Talking Crypto. Here’s What It Means for You …Congress is deep into “Crypto Week” — with new bills that could finally bring clarity to digital assets. Crypto analyst Juan Villaverde says Bitcoin will likely keep climbing… but smaller coins could deliver far bigger gains. He’s revealing the altcoins he believes are best positioned for this new regulatory era.July 20 at 2:00 AM | Weiss Ratings (Ad)Davenport Extreme Pools & Spas owner and spouse charged with fraud, theftOctober 6, 2023 | bizjournals.comPharmerica Stock Falls On Unusually High Volume (PMC)May 25, 2023 | thestreet.comActivities of Daily Living for SeniorsApril 20, 2023 | health.usnews.comGolden LivingFebruary 23, 2023 | forbes.comGas Cylinders Market Size in 2023 | Worldwide Industry Outlook, COVID-19 Impact, Market Trends, Share, Top Countries Data | Forecast Till 2028January 17, 2023 | marketwatch.comSee More Headlines PMC Stock Analysis - Frequently Asked Questions How were Pharmerica's earnings last quarter? Pharmerica Co. (NYSE:PMC) announced its earnings results on Thursday, November, 9th. The company reported $0.46 EPS for the quarter, missing the consensus estimate of $0.49 by $0.03. The firm earned $595.10 million during the quarter, compared to the consensus estimate of $596.80 million. What other stocks do shareholders of Pharmerica own? Based on aggregate information from My MarketBeat watchlists, some other companies that Pharmerica investors own include Cencora (COR), Capitol Federal Financial (CFFN), Bristol Myers Squibb (BMY), Tesla (TSLA), Depomed (DEPO), Inovio Pharmaceuticals (INO) and Bioblast Pharma (ORPN). Company Calendar Last Earnings11/09/2017Today7/19/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorN/A Industry N/A Sub-IndustryHealth Care Distributors Current SymbolNYSE:PMC CIK1388195 Webwww.pharmerica.com Phone+1-502-6277000FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free Report This page (NYSE:PMC) was last updated on 7/20/2025 by MarketBeat.com Staff From Our PartnersBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredThis Could Be the Most Profitable Season of Your LifeInstitutional money is pouring in. Bitcoin ETFs are live. Altcoin adoption is accelerating. This is the sam...Crypto Swap Profits | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pharmerica Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pharmerica With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.